<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7905589</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6173</journal-id>
<journal-id journal-id-type="nlm-ta">Neurotoxicology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotoxicology</journal-id>
<journal-title-group>
<journal-title>Neurotoxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0161-813X</issn>
<issn pub-type="epub">1872-9711</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27979773</article-id>
<article-id pub-id-type="pmc">5367381</article-id>
<article-id pub-id-type="doi">10.1016/j.neuro.2016.12.003</article-id>
<article-id pub-id-type="manuscript">NIHMS837477</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Zinc gluconate toxicity in wild-type vs. MT1/2-deficient mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hsieh</surname>
<given-names>Heidi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horwath</surname>
<given-names>Michael C.</given-names>
</name>
<xref ref-type="aff" rid="A2">3</xref>
<xref ref-type="aff" rid="A3">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Genter</surname>
<given-names>Mary Beth</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267-0056</aff>
<aff id="A2"><label>3</label>Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267-0557</aff>
<aff id="A3"><label>4</label>Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229</aff>
<author-notes>
<corresp id="FN1"><label>5</label>Corresponding author: Dr. Mary Beth Genter, Department of Environmental Health, ML 670056, 160 Panzeca Way, Room 144, University of Cincinnati, Cincinnati, OH 45267-0056, (513) 558-6266; <email>Marybeth.genter@uc.edu</email></corresp>
<fn fn-type="present-address" id="FN2">
<label>2</label>
<p>Present address: Covance, Inc., Madison, WI</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>58</volume>
<fpage>130</fpage>
<lpage>136</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuro.2016.12.003-->
<abstract>
<p id="P1">Previous studies have suggested that oral zinc supplementation can help reduce the duration of the common cold; however, the use of intranasal (IN) zinc is strongly associated with anosmia, or the loss of the sense of smell, in humans. Prior studies from this lab showed that upregulation of metallothioneins (MT) is a rapid and robust response to zinc gluconate (ZG). Therefore, we assessed the role of MT in the recovery of nasal epithelial damage resulting from IN zinc administration. The main studies in this investigation used a high dose of ZG (170 mM) to ensure ablation of the olfactory mucosa, so that the progression of histological and functional recovery could be assessed. In vivo studies using wild-type, MT1/2 knockout mice (MT KO), and heterozygotes administered ZG by IN instillation showed profound loss of the olfactory mucosa in the nasal cavity. Recovery was monitored, and a lower percentage of the MT KO mice were able to smell 28 d after treatment; however, no significant difference was observed in the rate of cell proliferation in the basal layer of the olfactory epithelium between MT KO and wild-type mice. A lower concentration of ZG (33 mM), equivalent to that found in homeopathic IN ZG preparations, also caused olfactory epithelial toxicity in mice. These studies suggest that the use of zinc in drug formulations intended for IN administration in humans must be carefully evaluated for their potential to cause olfactory functional deficits.</p>
</abstract>
<kwd-group>
<kwd>Metallothionein</kwd>
<kwd>zinc</kwd>
<kwd>olfactory</kwd>
<kwd>intranasal</kwd>
<kwd>olfactory behavior</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>